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Objectives: The incidence of anal disease is higher among persons with human
immunodeficiency virus (HIV) infection than among the general population. We
surveyed the status of seroprevalence in colorectal hospitals in Korea.
Methods: The survey was conducted in colorectal hospitals in Korea from
November to December 2008. The questionnaire was comprised of six topics
about the status of HIV testing in colorectal hospitals. We gathered the data by
website (http://hivqa.nih.go.kr/risk) or fax.
Results: Among 774 colorectal hospitals contacted, 109 (14%) hospitals partic-
ipated in the survey. Among these, 48 hospitals (44%) performed HIV tests in
their own hospitals and 11 (23%) took HIV testing by rapid method. The main
reason for recommending an HIV test was surgical operation (54%) followed by
endoscope (11%) and health checkup (9%). The annual number of HIV tests
increased from 58,647 (at 21 hospitals) in 2002 to 246,709 (at 58 hospitals) in
2007. HIV seroprevalence was >3.0 per 10,000 individuals during 2002e2005,
decreased to 2.2 per 10,000 individuals in 2006 and rose to 2.8 per 10,000
individuals in 2007.
Conclusions: HIV seroprevalence of colorectal hospitals was more than twice
that of general hospitals in Korea. HIV surveillance systems based on colorectal
hospitals for HIV/AIDS transmission prevention by early HIV diagnosis are
needed.ibuted under the terms of the Creative Commons Attribution Non-Commercial License
y-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in
is properly cited.
ol and Prevention. Published by Elsevier. All rights reserved.
Table 1. Status of HIV test in colorectal hospitals in
Korea
No. casesa (%)
Responding hospitals 109 (100)
Where to perform HIV test
Independent HIV test in-hospital 48 (44.0)
Refer to clinical laboratory 54 (49.5)
No HIV test 7 (6.5)
Case of recommendation for HIV testa
Operation 59 (54.1)
Endoscope 12 (11.0)
Health checkup 10 (9.2)
Suspected HIV infection 60 (55.0)
Necessity of HIV test before endoscopy
Yes 44 (40.4)
No 62 (56.9)
No response 3 (2.8)
Reason for not performing HIV test before endoscopy
Refusal by a patient 12 (11.0)
Not covered by insurance 51 (46.8)
Not necessary 37 (33.9)
No response 9 (8.3)
aMultiple responses allowed.
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In Korea, the major route of HIV transmission is
sexual contact (99%) and the ratio of men to women for
HIV positivity is 11:1. The proportion of men who have
sex with men (MSM) was approximately 40% of those
infected [1]. MSM are known to have more anorectal
diseases compared with the general population [2], and
anal sex enhances HIV infection risk [3].
Patients with HIV are chronically immunosup-
pressed, which may increase their risk for development
of malignancies [4,5]. In many studies, HIV infection
led to significantly increased rates of several cancers,
including Hodgkin’s disease, multiple myeloma, brain
cancer, and seminoma [6]. Anal cancer and its precursor
anal intraepithelial neoplasia have a high prevalence in
the HIV-positive population [7]. The relative risk for
developing anal cancer among HIV-positive MSM is 37
times higher than for the general population [8].
Neoplastic lesions of colorectum detected by endos-
copy (colonoscopy or sigmoidoscopy) were significantly
more common in HIV-infected patients than in control
subjects without HIV [9]. Colorectal cancer is the third
most common cancer (13%) in Korea, with >7100
deaths resulting from the disease in 2009 [10].
With recent increases in the number of specialized
colorectal clinics and hospitals, persons who develop
anorectal diseases due to anal intercourse or HIV
infections tend to be treated in these centers. HIV-
infected persons have more anorectal diseases, and the
most frequent reason to undergo surgical operation is
anorectal diseases [11e13]. Therefore, this study aimed
to identify HIV seroprevalence among patients in ano-
rectal clinics/hospitals in Korea.
2. Methods
2.1. Data collection
The survey was conducted in colorectal hospitals in
Korea from November to December 2008 and was co-
sponsored by the Korea Centers for Disease Control
(KCDC) and the Korean Society of Coloproctology
(KSC). The Division of AIDS of KCDC designed
a questionnaire to identify the status of HIV testing in
colorectal hospitals. KSC distributed the questionnaire to
774 colorectal hospitals in Korea. KCDC gathered the
data by the website (http://hivqa.nih.go.kr/risk) or by fax.
The questionnaire comprised six topics aboutHIV testing,
such as whether the colorectal hospital tested for HIV in
their own hospital, the methods of HIV test, the reason for
recommendation of HIV test to patients, the necessity for
HIV test under endoscopy, and the annual number of HIV
tests (2002e07).
2.2. HIV testing system
InKorea,HIV reactive samples fromprimary screening
tests in hospital laboratories or clinical laboratories arereferred to 17 local sites of the Institutions of Health and
the Environment (IHE) for confirmatory tests. Uncon-
firmed reactive samples are referred to the Division of
AIDS at KCDC, where final decision on HIV infection
status for each sample is made. The results of positivity
from IHE or from Division of AIDS are reported to the
Division of HIV and TB control at KCDC,whichmanages
the national HIV/AIDS database [14].
2.3. Statistical methods
HIV seroprevalence is defined as the number of HIV-
infected individuals divided by the total number of HIV-
tested individuals in a single year during the study
period. The number of HIV-tested individuals was
calculated by the repeated value per person-year from
previous study on hospital-based HIV seroprevalence in
Korea. The repeated value of HIV test per person-year
during 2002-07 was follows: 1.021, 1.024, 1.030, 1.030,
1.041 and 1.044, respectively [15]. Statistical analysis
was performed using the c2 test. A p-value <0.05 was
considered statistically significant.
3. Results
The survey included 109 (14%) of 774 colorectal
hospitals in Korea. Table 1 shows the status of HIV test
in colorectal hospitals. HIV test was taken in 102
hospitals (94%) and 48 hospitals (44%) performed HIV
test in-house. The main reason for recommending an
HIV test to patients was for operation (54%) followed
by for endoscope (11%) and on health checkup (9%).
HIV test before endoscopy was deemed necessity in 44
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Figure. Comparison of HIV seroprevalence between general
hospitals and colorectal hospitals (2002e07). The HIV sero-
prevalence is the number of the HIV infected per 10,000
individuals.
Table 2. Initiation and method of HIV tests in 48 colo-
rectal hospitals in Korea
No. cases (%)
Starting year of HIV test
Before 1990 7 (14.6)
1990e1999 10 (20.8)
2000e2009 31 (64.6)
Testing method
ELISA (Ab) 14 (29.2)
ELISA (Ag þAb) 22 (45.8)
Rapid test 11 (22.9)
No response 1 (2.1)
106 M.-K. Kee, et al(40%) of responding hospitals. The major reason for not
doing an HIV test before endoscopy was that it was not
covered by insurance (47%), followed by it was deemed
unnecessary (34%).
The status of HIV tests in 48 colorectal hospitals
performing HIV tests in-house are shown in Table 2.
Thirty-one (65%) hospitals began to take HIV tests from
2000. Antigen/antibody enzyme-linked immunosorbent
assay (ELISA) was performed in 22 hospitals (46%).
Table 3 shows the annual number of HIV tests and
HIV seroprevalence in colorectal hospitals from 2002
through 2007. The annual number of HIV test increased
from 58,647 (at 21 hospitals) in 2002 to 246,709 (at 58
hospitals) in 2007. HIV seroprevalence was >3.0 per
10,000 individuals until 2005, decreased to 2.2 per
10,000 individuals in 2006, and increased to 2.8 per
10,000 individuals in 2007.4. Discussion
We looked at the status of HIV tests and HIV sero-
prevalence in colorectal hospitals, which treat more
patients with benign anal diseases than general hospitals.
HIV tests in colorectal hospitals were performed before
surgical operations and when HIV infection was sus-
pected. During the analyzed period, HIV seroprevalence
of patients in colorectal hospitals was 2.2e3.9 per 10,000
individuals, whereas that in hospitals/clinics was 1.1e1.5
in Korea [15]. HIV seroprevalence in colorectal hospitals
was thus 2e3 times higher than that of general hospitals/Table 3. Number of HIV tests and HIV seroprevalence in colo
2002 2003
No. hospitals 21 31
No. HIV test 58,647 147,395
No. detection of HIV 21 51
HIV seroprevalence 3.7 3.5
HIV seroprevalence is the number of the HIV-infected per 10,000 individualsclinics (Figure). The number of individuals taking HIV
test has increased in colorectal hospitals and general
hospitals/clinics. The effect of increased numbers of HIV
test takerswas contrasting;HIV seroprevalence in general
hospitals/clinics has not increased because of a rough
balance between the number of HIV-infected individuals
and test takers, whereas that in colorectal hospitals has
decreased because of higher proportional increases in the
latter than the former parameter.
Koreans aged in their 50s are advised to take periodical
colonoscopies for early detection of colorectal cancer,
which has one of the highest prevalences among malig-
nancies in Korea [16]. As the number of colonoscopy
increases, so does the risk of infection by colonoscopy.
However, our results showed that the decision to under-
take HIV tests prior to colonoscopy was not governed by
necessity, but rather by health insurance coverage.
Korean health insurance policy deems that only the
following cases are covered by health insurance for HIV
tests: organ transplant; patients scheduled for surgical
operation or transfusion, severely infected patients,
patients with pyrexia of unknown origin, dialysis,
untypical skin ailment or lymphatic swelling of unknown
origin, homosexuals, prostitutes, injection drug users with
histories of sexually transmitted disease and possible HIV
infection, others suspected for HIV infection, and preg-
nant women [17]. Most of the cases in colorectalrectal hospitals, 2002e2007
2004 2005 2006 2007
35 45 52 58
164,022 200,013 223,311 246,709
50 75 47 65
3.1 3.9 2.2 2.8
.
Table 4. Annual insurance claim proportion for HIV testing in colorectal hospitals in Korea
2002 2003 2004 2005 2006 2007
Insurance claim proportion (%)a 69.7 34.6 34.0 35.4 33.9 25.7
aInsurance claim proportion, (no. insurance claims for HIV test/no. of HIV tests)  100.
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operation or transfusion and suspected for HIV infection.
In this study, the proportion of HIV test fees not
covered by national health insurance decreased since
2002. In 2002, the insurance claim for HIV tests at
colorectal hospitals was much higher than that of
general hospitals, but each year the claim decreased,
finally to the level of general hospitals (Table 4). This
can be interpreted as being that HIV tests were per-
formed for patients eligible for insurance claim in 2002,
whereas thereafter the population enlarged to include
those who were not eligible for insurance, and so that
the HIV seroprevalence in 2006 and 2007 decreased
although the number of HIV tests and confirmed HIV-
infected patients increased in colorectal hospitals.
HIV tests are necessary to prevent infection during
diagnosis and treatment such as transfusion and to
prevent transmission by persons who do not know that
they are HIV infected. A recent study on the survival rate
of HIV-infected persons suggests that if they are identi-
fied and receive adequate treatment they can extend their
lives by 16e30 years [18]. To prevent HIV infection and
to extend the survival time of HIV infected individuals
by early detection, US Centers for Disease Control
recommends that all Americans aged 13e64 years take
HIV tests. Furthermore, high-risk groups should take the
tests every year [19]. Korea has also run more active
program for early detection since 2008; anonymous tests
extended to hospitals.
Moreover, most newly identified infected persons start
undergoing immediate treatment due to detection in late
disease progression [20]; 700e800 newly identified HIV
infected persons are added each year. However, we need
to improve the current national surveillance system in
Korea. More than 70% of HIV-infected persons are
identified by tests in hospitals/clinics. We developed
methods to estimate HIV tests and HIV seroprevalence in
previous study [15]. Our next study will investigate
departmental differences of HIV seroprevalence in
hospitals/clinics because we noticed that a high seropre-
valence in a branch of colorectal hospitals in this study.
This study has two main limitations. First, we applied
the numbers of repeat tests from theprevious studyonHIV
seroprevalence in general hospitals/clinics to estimate the
HIV seroprevalence in colorectal hospitals. Second, the
low response rate (14%) may have led to selection bias;
most responding hospitals were large-sized hospitals.
HIV/AIDS in Korea is mainly infected by sexual
contact and is dominated by infected men. Thischaracteristic supports our study results on colorectal
hospitals and suggests that the national HIV surveillance
system should be fortified for colorectal patients.
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